The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists
about
Identification of mosaic and segmental aneuploidies by next-generation sequencing in preimplantation genetic screening can improve clinical outcomes compared to array-comparative genomic hybridization.A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical useRecurrent pregnancy loss: current perspectivesCost-effectiveness of preimplantation genetic screening for women older than 37 undergoing in vitro fertilization.Preimplantation genetic screening 2.0: the theoryEquipoise and the RCT.Preimplantation genetic screening-23 years to navigate and translate into the clinical arena. We need a new roadmap!Earlier day of blastocyst development is predictive of embryonic euploidy across all ages: essential data for physician decision-making and counseling patients.Developmental outcome of 9-year-old children born after PGS: follow-up of a randomized trial.Mosaicism: throwing the baby out with the bath water?Importance of embryo aneuploidy screening in preimplantation genetic diagnosis for monogenic diseases using the karyomap gene chip.Morphological embryo selection: an elective single embryo transfer proposal.Adjuncts in the IVF laboratory: where is the evidence for 'add-on' interventions?Novel technologies emerging for preimplantation genetic diagnosis and preimplantation genetic testing for aneuploidy.Recent developments in genetics and medically assisted reproduction: from research to clinical applications
P2860
Q33604625-7BEB3C2B-D032-4308-8948-3D949E0491E1Q33612541-B87780ED-93BD-4963-9990-029C313DD93BQ33713930-E23348F2-5EF4-403A-B332-8E88A5CA938CQ38658432-3478D28F-A258-4A6B-886F-2E69762E8067Q38852209-04B49CA8-3391-4025-8EAC-82C80D4E0325Q39101761-A0A940E5-0421-441A-9BE4-4134ECC44213Q42353993-1E17AA64-3760-4084-AD1C-39C831792259Q46230996-7A678C82-5714-4408-A6F3-D691526F4197Q47217831-D072A4CF-BAA7-4C93-B703-D7145EC471FBQ49294968-1187B1DE-4A95-476F-BB74-5D238DE361FAQ49912258-EE63D037-B573-45A7-9020-639EAF5791DFQ50026138-7F31DFAB-8034-48FE-893C-E41FCF9AAECEQ50913286-42D9BDD8-B783-4223-AF15-D8DB0AD4BF92Q53677632-29C2B411-3803-48C8-BBE0-A42CDF471874Q56927575-D273A6F2-29D5-49E3-ACBA-B7976C8432D7
P2860
The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The why, the how and the when ...... biologists, and embryologists
@en
type
label
The why, the how and the when ...... biologists, and embryologists
@en
prefLabel
The why, the how and the when ...... biologists, and embryologists
@en
P2093
P2860
P50
P356
P1476
The why, the how and the when ...... biologists, and embryologists
@en
P2093
Alan Handyside
Carmen Rubio
Dagan Wells
David Meldrum
Edith Coonen
Filippo Ubaldi
Francesco Fiorentino
Georg Griesinger
Georgia Kokkali
Jacques Cohen
P2860
P304
P356
10.1093/MOLEHR/GAW034
P50
P577
2016-06-02T00:00:00Z